Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Treatment of relapse after allogeneic hematopoietic stem cell transplantation (alloHSCT) remains a great challenge. Aiming to evaluate the combination of venetoclax and hypomethylating agents (HMAClax) for the treatment of relapse of myeloid malignancies after alloHSCT, we retrospectively collected...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuler, Esther, Wagner-Drouet, Eva-Maria, Ajib, Salem, Bug, Gesine, Crysandt, Martina, Dressler, Sabine, Hausmann, Andreas, Heidenreich, Daniela, Hirschbühl, Klaus, Hoepting, Matthias, Jost, Edgar, Kaivers, Jennifer, Klein, Stefan, Koldehoff, Michael, Kordelas, Lambros, Kriege, Oliver, Müller, Lutz P., Rautenberg, Christina, Schaffrath, Judith, Schmid, Christoph, Wolff, Daniel, Haas, Rainer, Bornhäuser, Martin, Schroeder, Thomas, Kobbe, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448702/
https://www.ncbi.nlm.nih.gov/pubmed/33191481
http://dx.doi.org/10.1007/s00277-020-04321-x

Ejemplares similares

Ejemplares similares